Nasdaq
$0.1886▲ 2.78%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $9.7MShares out 51.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
16- 10.16Pre-market26.10.16 19:036-KKey event#●●●#●●●
MDxHealth SABullish
MDxHealth expects Q3 2026 revenue of approximately $22.7 million and has withdrawn its full-year 2026 revenue guidance of $110–115 million due to unexpected sales force turnover. As of September 30, 2026, the company held approximately $31.7 million in cash and cash equivalents, with further details on corrective actions to be provided during the earnings call on November 12.…more
$0.1886+2.78%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 05:08SCHEDULE 13D/AOwnership
MDxHealth SA
A major shareholder of MDxHealth SA sold a total of 1,126,636 shares between September 17, 2026, and October 13, 2026. During this period, the shares were sold at prices ranging from $0.5104 to $0.6733 per share.…more
$0.1886+2.78%vs prev closeView filingShare - 9.17After-hours26.09.18 06:42144Ownership
MDxHealth SA
Bleichroeder LP has filed SEC Form 144 to report the proposed sale of MDxHealth SA (MDXH) shares. This filing indicates the intent of a major shareholder to sell their holdings, which may lead to an increase in the circulating supply of the stock.…more
$0.1886+2.78%vs prev closeView filingShare
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15After-hours26.10.16 05:00Bullish#●●●#●●●
MDxHealth Reports Weak Q3 Results and Suspends Full-Year Guidance
MDxHealth announced that its third-quarter revenue fell short of expectations and suspended its full-year 2026 revenue guidance. The company attributed the performance shortfall to unexpected turnover within its sales force.…more
$0.1886+2.78%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.13After-hours26.08.14 05:00
●●●●●●●● ●●●●● ●●●●●●
MDxHealth reported a 16% year-over-year revenue increase to $27.2 million in Q2, while simultaneously executing a $20 million registered direct placement to strengthen its balance sheet. The company has discontinued its non-core Resolve business to focus exclusively on its core prostate cancer diagnostic operations.…more
$0.1886+2.78%vs prev close - 7.30After-hours26.07.31 05:00
●●●●●●●● ●●●●● ●●●●●●
정밀 진단 기업 MDX헬스가 오는 8월 13일 장 마감 후 2분기 실적을 발표하고 컨퍼런스 콜을 진행합니다. 최근 나스닥 상장 유지 조건 미달 통보를 받은 상황이라 이번 실적 발표에서 향후 경영 계획이 주목됩니다.…more
$0.1886+2.78%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report